Skip to main content

Table 5 Primary and secondary outcomes

From: Implementation of HPV-based screening in Burkina Faso: lessons learned from the PARACAO hybrid-effectiveness study

 

Overall

Center A

Center B

p value

Screening completeness

    

HPV-negative women, the results given

247/249 (99.2)

127/128 (99.2)

120/121 (99.2)

1

HPV-positive women, VIA done and negative

49/55 (89.1)

21/25 (84.0)

28/30 (93.3)

0.56

HPV-positive women, VIA positive and treatment provided

3/6 (50.0)

2/4 (50.0)

1/2 (50.0)

1

Women with complete screening sequencea

299/317 (94.3)

150/160 (93.8)

149/157 (94.9)

0.84

Women satisfaction (high vs low)b

    

Postsampling

205/317 (64.7)

128/160 (80.0)

77/157 (49.0)

< 0.001

Postresults

300/315 (94.6)

146/158 (91.2)

154/157 (98.1)

0.014

Post-VIA

38/55 (69.1)

15/25 (60.0)

23/30 (76.7)

0.29

  1. Data are number of women (%)
  2. aScreening sequence was considered complete when an HPV-negative woman was informed of the result of the HPV test, when an HPV-positive woman had a subsequent negative VIA test, or when an HPV-positive woman with a subsequent positive VIA test had an appropriate treatment
  3. bSatisfaction was assessed at three steps: after vaginal sampling (postsampling); after women received their test results (postresults); and after the visual inspection if relevant (post-VIA)
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us